Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson’s disease

References

• Annett LE, Rogers DC, Hernandez TD, Dunnett SB. (1992). Behavioural analysis of unilateral monoamine depletion in the marmoset. Brain 115:825–56
   Google Scholar
• Anonymous. (1983). New hope for Parkinsonism. Chemical Week 27 April 1983, 331
   Google Scholar
• Anuradha CV, Ravikumar P. (2001). Restoration on tissue antioxidants by fenugreek seeds (Trigonella foenum graecum) in alloxan-diabetic rats. Indian J Physiol Pharmacol 45:408–20
   PubMedGoogle Scholar
• Beal MF. (2001). Experimental models of Parkinson’s disease. Nat Rev Neurosci 2:325–534
   PubMed Web of Science ®Google Scholar
• Berglund T. (1994). Nicotinamide, a missing link in the early stress response in eukaryotic cells: A hypothesis with special reference to oxidative stress in plants. FEBS Lett 351:145–9
   Google Scholar
• Cotzias GC, Papavasiliou PS, Gellene R. (1969). Modification of Parkinsonism – chronic treatment with L-dopa. N Engl J Med 280:337–45
   PubMed Web of Science ®Google Scholar
• Deumens R, Blokland A, Prickaerts J. (2002). Modeling Parkinson’s disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303–17
   PubMed Web of Science ®Google Scholar
• Devasena T, Menon VP. (2002). Enhancement of circulatory antioxidants by fenugreek during 1,2-dimethylhydrazine-induced rat colon carcinogenesis. J Biochem Mol Biol Biophys 6:289–92
   PubMedGoogle Scholar
• Devasena T, Menon VP. (2007). Fenugreek seeds modulate 1,2-dimethylhydrazine-induced hepatic oxidative stress during colon carcinogenesis. Ital J Biochem 56:28–34
   PubMedGoogle Scholar
• Dunnett SB, Bjorklund A. (1999). Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature 399:A32–9
   PubMed Web of Science ®Google Scholar
• Duvoisin RC. (1976). Parkinsonism: animal analogues of the human disorder. Res Publ Assoc Res Nerv Ment Dis 55:293–303
   Google Scholar
• Finnegan KT, Irwin I, Delanney LE, et al. (1987). 1,2,3,6-Tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Pharmacol Exp Ther 242:1144–51
   PubMed Web of Science ®Google Scholar
• Henchcliffe C, Beal MF. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neuro 4:600–9
   PubMedGoogle Scholar
• Hong BN, Yi TH, Park R, et al. (2008). Coffee improves auditory neuropathy in diabetic mice. Neurosci Lett 441:302–6
   PubMed Web of Science ®Google Scholar
• Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. (1995). Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257–69
   PubMedGoogle Scholar
• Javitch JA, Snyder SH. (1984). Uptake of MPP(+) by dopamine neurons explains selectivity of Parkinsonism-inducing neurotoxin, MPTP. Eur J Pharmacol 106:455–6
   Google Scholar
• Kaviarasan S, Ramamurty N, Gunasekaran P, et al. (2006). Fenugreek (Trigonella foenum graecum) seed extract prevents ethanol-induced toxicity and apoptosis in Chang liver cells. Alcohol Alcohol 41:267–73
   PubMed Web of Science ®Google Scholar
• Markham CH, Diamond SG. (1981). Evidence to support early levodopa therapy in Parkinson disease. Neurology 31:125–31
   PubMed Web of Science ®Google Scholar
• Mattila PM, Rinne JO, Helenius H, Roytta M. (1999). Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology. Acta Neuropathol (Berl) 98:157–64
   PubMed Web of Science ®Google Scholar
• McCall RB, Lookingland KJ, Bedard PJ, Huff RM. (2005). Sumanirole, a highly dopamine D2-selective receptor agonist: In vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson’s disease. J Pharmacol Exp Ther 314:1248–56
   PubMed Web of Science ®Google Scholar
• Meissner WG, Frasier M, Gasser T, et al. (2011). Priorities in Parkinson’s disease research. Nat Rev Drug Discov 10:377–93
   PubMed Web of Science ®Google Scholar
• Mishkinsky J, Joseph B, Sulman FG. (1967). Hypoglycaemic effect of trigonelline. Lancet 2:1311–12
   PubMed Web of Science ®Google Scholar
• Nadkarni AK. (1990). The Indian Materia Medica. Bombay, India: Popular Prakashan Pvt Ltd
   Google Scholar
• Nayak L, Henchcliffe C. (2008). Rasagiline in treatment of Parkinson’s disease. Neuropsychiatr Dis Treat 4:23–32
   PubMedGoogle Scholar
• Nicklas WJ, Vyas I, Heikkila RE. (1985). Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36:2503–8
   PubMed Web of Science ®Google Scholar
• Papapetropoulos S, Basel M, Mash DC. (2007). Dopaminergic innervation of the human striatum in Parkinson’s disease. Mov Disord 22:286–8
   Google Scholar
• Paxinos G, Watson C. (2007). The Rat Brain in Stereotaxic Coordinates. 6th ed. Amsterdam, The Netherlands: Elsevier
   Google Scholar
• Pellegrino LJ, Pellegrino AS, Cushman AJ. (1979). A Stereotaxic Atlas of the Rat Brain. 2nd ed. New York, NY: Plenum Press
   Google Scholar
• Petropoulos GA. (2002). Fenugreek: The Genus Trigonella. New York, NY: Taylor and Francis
   Google Scholar
• Preet A, Gupta BL, Siddiqui MR, et al. (2005). Restoration of ultrastructural and biochemical changes in alloxan-induced diabetic rat sciatic nerve on treatment with Na3VO4 and Trigonella – a promising antidiabetic agent. Mol Cell Biochem 278:21–31
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, Irwin I, Forno LS, et al. (1987). Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res 403:43–51
   PubMed Web of Science ®Google Scholar
• Ruberg M, Scherman D, Javoy-Agid F, Agid Y. (1995). Dopamine denervation, age of onset, and Parkinson’s disease. Neurology 45:392
   PubMedGoogle Scholar
• Saravanan R, Pari L. (2005). Antihyperlipidemic and antiperoxidative effect of diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement Altern Med 5:1–8
   PubMedGoogle Scholar
• Schober A. (2004). Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215–24
   PubMed Web of Science ®Google Scholar
• Shah S, Bodhankar SL, Badole SL, et al. (2006). Effect of trigonelline: An active compound from Trigonella foenum graecum Linn. in alloxan induced diabetes in mice. J Cell Tissue Res 6:585–90
   Google Scholar
• Silva MA, Mattern C, Hacker R, et al. (1997). Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: On the role of benserazide pretreatment. Synapse 27:294–302
   Google Scholar
• Takeuchi H, Takahashi R. (2007). Pathogenesis of Parkinson disease. Nippon Ronen Igakkai Zasshi 44:415–21
   Google Scholar
• Tohda C, Kuboyama T, Komatsu K. (2005). Search for natural products related to regeneration of the neuronal network. NeuroSignals 14:34–45
   PubMed Web of Science ®Google Scholar
• Tohda C, Nakamura N, Komatsu K, Hattori M. (1999). Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol Pharm Bull 22:679–82
   Google Scholar
• Tuite P, Riss J. (2003). Recent developments in the pharmacological treatment of Parkinson’s disease. Expert Opin Investig Drugs 12:1335–52
   PubMed Web of Science ®Google Scholar
• Ungerstedt U. (1971a). Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:95–122
   PubMedGoogle Scholar
• Ungerstedt U. (1971b). Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 367:49–68
   Google Scholar
• Urban P, Andersen JK, Hsu HP, Pompon D. (1991). Comparative membrane locations and activities of human monoamine oxidases expressed in yeast. FEBS Lett 286:142–6
   PubMed Web of Science ®Google Scholar
• Yen WJ, Wang BS, Chang LW, Duh PD. (2005). Antioxidant properties of roasted coffee residues. J Agric Food Chem 53:2658–63
   PubMed Web of Science ®Google Scholar
• Youdim MB, Finberg JP. (1991). New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochem Pharmacol 41:155–62
   PubMed Web of Science ®Google Scholar
• Yuyama S, Suzuki T. (1985). Isolation and identification of N1-methylnicotinic acid (trigonelline) from rat urine. J Nutr Sci Vitaminol (Tokyo) 31:157–67
   PubMed Web of Science ®Google Scholar